» Articles » PMID: 16940164

Pneumocystis Jiroveci Infection in Patients with Hyper-immunoglobulin E Syndrome

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2006 Aug 31
PMID 16940164
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The hyper-immunoglobulin E syndrome is a primary immunodeficiency characterized by recurrent pyogenic skin and lung abscesses, dermatitis, and elevated serum immunoglobulin E levels. Pneumocystis jiroveci (formerly Pneumocystis carinii) is not typically associated with hyper-immunoglobulin E syndrome. We identified 7 patients with hyper-immunoglobulin E syndrome with P. jiroveci detected in respiratory or pulmonary pathology specimens. In 5 patients it was the sole pathogen, and in 2 other patients it contributed to a polymicrobial etiology. No consistent prophylaxis was given, and there have been no recurrences on long-term follow-up. Our experience suggests that P. jiroveci can cause pneumonia in patients with hyper-immunoglobulin E syndrome both with and without chronic lung disease.

Citing Articles

Infections in Inborn Errors of STATs.

Wang C, Freeman A Pathogens. 2024; 13(11).

PMID: 39599507 PMC: 11597637. DOI: 10.3390/pathogens13110955.


Immunomodulatory Plant Natural Products as Therapeutics against Inflammatory Skin Diseases.

Kumar N, Reddy N, Kumar H, Vemireddy S Curr Top Med Chem. 2024; 24(12):1013-1034.

PMID: 38485678 DOI: 10.2174/0115680266277952240223120435.


Early intervention in STAT3 dominant negative disease.

An Z, Williams K, Urban A, Ali S, Roy S, Lafeer C J Allergy Clin Immunol Pract. 2023; 11(12):3795-3798.e1.

PMID: 37683824 PMC: 10841703. DOI: 10.1016/j.jaip.2023.08.044.


JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences.

Ott N, Faletti L, Heeg M, Andreani V, Grimbacher B J Clin Immunol. 2023; 43(6):1326-1359.

PMID: 37140667 PMC: 10354173. DOI: 10.1007/s10875-023-01483-x.


Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients.

Ibrahim A, Chattaraj A, Iqbal Q, Anjum A, Ur Rehman M, Aijaz Z Avicenna J Med. 2023; 13(1):23-34.

PMID: 36969352 PMC: 10038753. DOI: 10.1055/s-0043-1764375.